Lupin gets USFDA OAI status for Pithampur Unit 2 facility Ruchika Sharma5 Oct 2025 11:00 AM ISTMumbai: Lupin has announced that the U.S. Food and Drug Administration (USFDA) has issued Official Action Indicated (OAI) status for the...
Lupin unveils Liraglutide Injection in US for diabetes Ruchika Sharma4 Oct 2025 10:32 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Liraglutide Injection, 18 mg/3 mL (6 mg/mL) Single-Patient-Use Prefilled Pen,...
Lupin: Manufacturing Operations President Rajendra Chunodkar retires Ruchika Sharma2 Oct 2025 2:15 PM ISTMumbai: Lupin has announced the retirement of Rajendra Chunodkar, President - Manufacturing Operations and a member of the Senior Management of the...
Lupin unveils Rivaroxaban for Oral Suspension in US following USFDA approval Ruchika Sharma2 Oct 2025 2:00 PM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Rivaroxaban for Oral Suspension, 1 mg/mL, in the United...
Lupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric patients Ruchika Sharma1 Oct 2025 11:37 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Lupin gets tentative USFDA nod for HIV drug Ruchika Sharma24 Sept 2025 5:16 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
Intas Pharma appoints Ajay Tiwari as President - HR Ruchika Sharma23 Sept 2025 1:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Ajay Tiwari as President - Human Resources."Throughout his journey, Ajay has been...
Lupin gets 4 USFDA observations for Pune Biotech facility Ruchika Sharma20 Sept 2025 2:45 PM ISTMumbai: Lupin has announced that the company has received four observations from the U.S. Food and Drug Administration (USFDA) after an inspection at...
Lupin Secures CDSCO Panel Clearance for Phase III COPD Inhaler Trial Parthika Patel19 Sept 2025 3:00 PM ISTNew Delhi: Lupin Limited has received recommendations from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization...
Lupin Secures CDSCO Panel Nod for Phase IV Trial of Budesonide-Based COPD Inhaler Parthika Patel18 Sept 2025 6:45 PM ISTNew Delhi: Lupin Limited has received recommendations from the Subject Expert Committee, under the Central Drugs Standard Control Organization (CDSCO)...
Lupin bags USFDA approval for Multiple myeloma treatment Ruchika Sharma17 Sept 2025 6:19 PM ISTMumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food and Drug Administration...
Lupin gets 6 USFDA observations for Nagpur facility Ruchika Sharma17 Sept 2025 11:00 AM ISTMumbai: Lupin has announced that the U.S. Food and Drugs Administration (USFDA) has closed the inspection with six observations at the company's...
